A combination treatment approach using two chemotherapy drugs improved treatment response and progression-free survival in patients with advanced pancreatic neuroendocrine tumors, according to a recent clinical trial published in the Journal of Clinical Oncology.
Northwestern University scientists have discovered it is possible to isolate a tumor’s attack cells non-invasively from blood, rather than from tumors.
Northwestern investigators have formed an interdisciplinary group to address the global issue of antimicrobial resistance.
Repeat radiation therapy combined with monoclonal antibody treatment extended progression-free survival in patients with recurrent glioblastoma, according to a recent clinical trial published in the Journal of Clinical Oncology.
Alan Hauser, MD, PhD, vice chair of Microbiology-Immunology, has been named the new director of Feinberg’s Medical Scientist Training Program (MSTP), effective April 15.
Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new Northwestern Medicine study published in the American Journal of Preventive Medicine.
Two therapeutic drugs benefited mice with non-small cell lung cancer, potentially paving the way for clinical trials in humans.
Northwestern Medicine scientists have developed a wireless, self-powered, bioresorbable implant for programmed drug delivery, the details of which are published in PNAS.
The PrEP4Teens initiative received over $300,000 from from the Chicago Department of Public Health, Alphawood Foundation, Northwestern University Clinical and Translational Sciences Institute, and the Third Coast Center for AIDS Research.
In a recent editorial published in the Journal of Experimental Medicine, Cecilia Berin, PhD, discusses the current state of IgE-mediated food allergy treatments, targeting type 2 immune responses, and next steps for food allergy research and treatment development.